Oct 25 (Reuters) – Roche Holding AG: * ROCHE’S DIVARASIB DEMONSTRATED BEST-IN-CLASS EFFICACY, ADVANCING THE STANDARD OF CARE IN PREVIOUSLY TREATED KRAS G12C-MUTATED LUNG CANCER * ROCHE HOLDING AG –
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
(Adds game result, details) By Vincent Daheron PARIS, Oct 25 (Reuters) - The Pittsburgh Steelers…
(Adds Carrick quotes) LIVERPOOL, England, Oct 25 (Reuters) - Liverpool beat Brighton & Hove Albion…
Oct 25 (OPTA) - Summaries for the Bundesliga on Sunday (start times are CET) Hoffenheim…
Oct 25 (OPTA) - Final Rounds and Seeds Progress from the ATP500, Swiss Indoors Basel…
VIDEO SHOWS: ZURICH, SWITZERLAND (OCTOBER 24, 2026) (RED BULL CONTENT POOL - No resales. No…
Oct 25 (OPTA) - Summaries for the Eredivisie on Sunday (start times are CET) Fortuna…